1-13 of 13
Shoucheng Ning
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4358: The immunomodulatory anticancer agent RRx-001 induces a vaccine-like interferon response through epigenetic induction of viral mimicry

Free
Hongjuan Zhao, Shoucheng Ning, Rosalie Nolley, Jan Scicinski, Bryan Oronsky, Susan J. Knox, Donna M. Peehl
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4358.
https://doi.org/10.1158/1538-7445.AM2017-4358
Published: 01 July 2017
View articletitled, Abstract 4358: The immunomodulatory anticancer agent RRx-001 induces a vaccine-like interferon response through epigenetic induction of viral mimicry
Journal Articles

Abstract 4916: Improved statistical approaches that account for pseudoprogression in preclinical studies of RRx-001 with immunotherapies

Free
Nacer E. Abrouk, Jan Scicinski, Bryan Oronsky, Susan J. Knox, Donna Peehl, Shoucheng Ning, Gary R. Fanger
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4916.
https://doi.org/10.1158/1538-7445.AM2016-4916
Published: 15 July 2016
View articletitled, Abstract 4916: Improved statistical approaches that account for pseudoprogression in preclinical studies of RRx-001 with immunotherapies
Journal Articles

Abstract A1-35: RRx-001, a novel first in class epigenetic modulator, “episensitizes” colorectal patients to FOLFIRI: Preliminary resensitization data from the Phase 2 “ROCKET” study

Free
Tony Reid, Jennifer Carney, Keola Beale, Chan Clayton, Huy Nguyen, Cheryl Cho-Phan, Meaghan Stirn, Shoucheng Ning, Susan Knox, Bryan Oronsky, Jan Scicinski, Scott Caroen, Christopher Parker, Gary R. Fanger, George Fisher
Journal: Cancer Research
Cancer Res (2015) 75 (22_Supplement_1): A1-35.
https://doi.org/10.1158/1538-7445.TRANSCAGEN-A1-35
Published: 15 November 2015
View articletitled, Abstract A1-35: RRx-001, a novel first in class epigenetic modulator, “episensitizes” colorectal patients to FOLFIRI: Preliminary resensitization data from the Phase 2 “ROCKET” study
Journal Articles

Abstract 3515: RRx-001: A double action systemically non-toxic epigenetic agent for cancer therapy

Free
Hongjuan Zhao, Shoucheng Ning, Jan Scicinski, Bryan Oronsky, Susan Knox, Donna M. Peehl
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3515.
https://doi.org/10.1158/1538-7445.AM2015-3515
Published: 01 August 2015
View articletitled, Abstract 3515: RRx-001: A double action systemically non-toxic epigenetic agent for cancer therapy
Journal Articles

Abstract 906: Molecular imaging of RRx-001-induced oxidative stress in Nrf2-luciferase expressing SCC VII tumors in mice

Free
Shoucheng Ning, Thillai Veerapazham Sekar, Ramasamy Paulmurugan, Jan Scicinski, Bryan Oronsky, Donna Peehl, Susan J. Knox
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 906.
https://doi.org/10.1158/1538-7445.AM2014-906
Published: 01 October 2014
View articletitled, Abstract 906: Molecular imaging of RRx-001-induced oxidative stress in Nrf2-luciferase expressing SCC VII tumors in mice
Journal Articles

Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials

Available to Purchase
Shoucheng Ning, Mark Bednarski, Bryan Oronsky, Jan Scicinski, Gordon Saul, Susan J. Knox
Journal: Cancer Research
Cancer Res (2012) 72 (10): 2600–2608.
https://doi.org/10.1158/0008-5472.CAN-11-2303
Published: 14 May 2012
View articletitled, Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials
Open the PDF for Dinitroazetidines Are a Novel Class of Anticancer Agents and Hypoxia-Activated Radiation Sensitizers Developed from Highly Energetic Materials in another window
Journal Articles

Abstract 4371: RRx-001 modulates intratumor blood flow in SCCVII and U87 tumors

Free
Jan Scicinski, Bryan Oronsky, Shoucheng Ning, Andrew Minchinton, Susan Knox
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4371.
https://doi.org/10.1158/1538-7445.AM2012-4371
Published: 15 April 2012
View articletitled, Abstract 4371: RRx-001 modulates intratumor blood flow in SCCVII and U87 tumors
Journal Articles

Abstract 676: Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materials

Free
Shoucheng Ning, Mark Bednarski, Bryan Oronsky, Jan Scicinski, Gordon Saul, Susan J. Knox
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 676.
https://doi.org/10.1158/1538-7445.AM2011-676
Published: 15 April 2011
View articletitled, Abstract 676: Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materials
Journal Articles

Anti–αv Integrin Monoclonal Antibody Intetumumab Enhances the Efficacy of Radiation Therapy and Reduces Metastasis of Human Cancer Xenografts in Nude Rats

Available to Purchase
Shoucheng Ning, Junqiang Tian, Deborah J. Marshall, Susan J. Knox
Journal: Cancer Research
Cancer Res (2010) 70 (19): 7591–7599.
https://doi.org/10.1158/0008-5472.CAN-10-1639
Published: 29 September 2010
View articletitled, Anti–αv Integrin Monoclonal Antibody Intetumumab Enhances the Efficacy of Radiation Therapy and Reduces Metastasis of Human Cancer Xenografts in Nude Rats
Open the PDF for Anti–αv Integrin Monoclonal Antibody Intetumumab Enhances the Efficacy of Radiation Therapy and Reduces Metastasis of Human Cancer Xenografts in Nude Rats in another window
Journal Articles

Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma

Free
Shoucheng Ning, Susan J. Knox
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 342.
Published: 01 May 2005
View articletitled, Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma
Journal Articles

Darbepoietin Alfa Potentiates the Efficacy of Radiation Therapy in Mice with Corrected or Uncorrected Anemia

Available to Purchase
Shoucheng Ning, Cynthia Hartley, Graham Molineux, Susan J. Knox
Journal: Cancer Research
Cancer Res (2005) 65 (1): 284–290.
https://doi.org/10.1158/0008-5472.284.65.1
Published: 21 January 2005
View articletitled, Darbepoietin Alfa Potentiates the Efficacy of Radiation Therapy in Mice with Corrected or Uncorrected Anemia
Open the PDF for Darbepoietin Alfa Potentiates the Efficacy of Radiation Therapy in Mice with Corrected or Uncorrected Anemia in another window
Journal Articles

Combination Therapy: Lonidamine, Hyperthermia, and Chemotherapy against the RIF-1 Tumor in Vivo

Available to Purchase
Shoucheng Ning, George M. Hahn
Journal: Cancer Research
Cancer Res (1991) 51 (21): 5910–5914.
Published: 01 November 1991
View articletitled, Combination Therapy: Lonidamine, Hyperthermia, and Chemotherapy against the RIF-1 Tumor in Vivo
Open the PDF for Combination Therapy: Lonidamine, Hyperthermia, and Chemotherapy against the RIF-1 Tumor in Vivo in another window
Journal Articles

Cytotoxicity of Lonidamine Alone and in Combination with Other Drugs against Murine RIF-1 and Human HT1080 Cells in Vitro

Available to Purchase
Shoucheng Ning, George M. Hahn
Journal: Cancer Research
Cancer Res (1990) 50 (24): 7867–7870.
Published: 01 December 1990
View articletitled, Cytotoxicity of Lonidamine Alone and in Combination with Other Drugs against Murine RIF-1 and Human HT1080 Cells in Vitro
Open the PDF for Cytotoxicity of Lonidamine Alone and in Combination with Other Drugs against Murine RIF-1 and Human HT1080 Cells in Vitro in another window